Working with the NCI
The National Cancer Institute recognizes that collaboration is critical to bringing the discoveries made at the research bench to the patient bedside. This is especially important in nanotechnology, where clinical researchers and physical scientists need to work together to translate the scientific discoveries into clinical interventions.
There are many opportunities for collaboration in nanotechnology with NCI-funded programs and centers. The NCI Alliance for Nanotechnology in Cancer focuses on nanotechnology, but there are other nanotechnology research components at NCI-designated Cancer Centers across the country specializing in both basic and translational research, within Specialized Programs of Research Excellence (SPOREs) set up to promote interdisciplinary research, or through CRADA programs designed to facilitate the commercialization of technology arising from Federal laboratories.
Find out more information about projects that are currently underway and identify opportunities for collaboration by visiting the NCI-affiliated websites below.